Young June Shin

Title: Young June Shin: Innovator in Pharmaceutical Compounds

Introduction

Young June Shin is a notable inventor based in Gimhae-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzyme activities. His work has the potential to impact the treatment of various metabolic disorders.

Latest Patents

Young June Shin holds a patent for a compound that inhibits the 11Beta-HSD1 enzyme. The patent describes a novel compound or a pharmaceutically acceptable salt that selectively inhibits the activity of 11β-HSD1 (11β-Hydroxysteroid dehydrogenase type 1). This compound can be effectively utilized as a therapeutic agent for conditions such as non-insulin dependent type II diabetes, insulin resistance, obesity, lipid disorders, and metabolic syndrome. The patent also includes a method for producing this compound and a pharmaceutical composition containing it as an active ingredient.

Career Highlights

Throughout his career, Young June Shin has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Ahn-gook Pharmaceutical Co., Ltd. and Bamichem Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Young June Shin has collaborated with several professionals in his field, including Soon Kil Ahn and Jin Auh. These collaborations have likely enhanced his research and development efforts, leading to advancements in pharmaceutical compounds.

Conclusion

Young June Shin is a distinguished inventor whose work in developing compounds that inhibit specific enzyme activities holds promise for treating various metabolic diseases. His contributions to the pharmaceutical industry are noteworthy and reflect his commitment to innovation in healthcare.